Global Prostate-specific Antigen (PSA) Testing Market Growth (Status and Outlook) 2025-2031

According to this study, the global Prostate-specific Antigen (PSA) Testing market size will reach US$ 652 million by 2031.

Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK4 gene.



The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a la୐

The major players in global PSA Test market include Abbott, Siemens Healthcare, DiaSorin, etc. The top 3 players occupy about 50% shares of the global market. North America and Europe are main markets, they occupy over 81% of the global market. CLIA is th୅

LPI (LP Information)' newest research report, the “Prostate-specific Antigen (PSA) Testing Industry Forecast” looks at past sales and reviews total world Prostate-specific Antigen (PSA) Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Prostate-specific Antigen (PSA) Testing sales for 2025 through 2031. With Prostate-specific Antigen (PSA) Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prostate-specific Antigen (PSA) Testing industry.

This Insight Report provides a comprehensive analysis of the global Prostate-specific Antigen (PSA) Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Prostate-specific Antigen (PSA) Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prostate-specific Antigen (PSA) Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prostate-specific Antigen (PSA) Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prostate-specific Antigen (PSA) Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Prostate-specific Antigen (PSA) Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:
CLIA Method
ELISA Method

Segmentation by Application:
Screening
Post-treatment Monitoring
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Boston Scientific Corporation
Bayer AG
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
Merck＆Co.
Medtronic
Sanofi-Aventis SA

Please note: The report will take approximately 2 business days to prepare and deliver. Show more